

Inbec Tablet (Abacavir, Dolutegravir and Lamivudine)
Manufactured By
Emcure
Pack Of
30
Salt Composition
Abacavir, Dolutegravir and Lamivudine
Storage
Keep in cold place
Overview
Inbec Tablet (Abacavir/Dolutegravir/Lamivudine) is an antiviral medication that contains a combination of three drugs, such as Abacavir, Dolutegravir, and Lamivudine. It is prescribed for the treatment of HIV (human immunodeficiency virus) infection.
The medicine works by reducing the amount of HIV in the body by blocking key enzymes required for viral replication. This helps prevent the virus from multiplying and allows the immune system to function better.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | inbec |
| Generic / Active Ingredient | Indinavir |
| Strength | 400 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | emcure |
| Pack Size | 30 |
| Prescription Required | Yes |
| Therapeutic Categories | HIV Medicines |
| Uses | HIV |
Uses and Indications
HIV
Side Effects of Inbec Tablet
Inbec Tablet (Abacavir/Dolutegravir/Lamivudine) shows various side effects due to its action on viral enzymes. These effects can vary from person to person and are usually mild to moderate.
Patients should consult their healthcare expert if any of these symptoms persist:
● Insomnia
● Headache
● Fatigue
● Heart attack
● Hepatitis B reactivation
● Hypersensitivity allergic reaction
Inbec Tablet Dosage and How To Take It
The doctor determines the correct dose and duration of the Inbec tablet based on the patient's health and as per the severity of the infection to ensure safe and effective treatment. Take the tablet orally once a day as prescribed by the doctor.
Use the medicine at the same time every day to enhance the effectiveness of the treatment. Do not double up to make up for the missed one. Instead, take the next dose at the scheduled time and consult your doctor if you have any concerns.
Safety Advice for Inbec Tablet
- ● Alcohol: Alcohol is strictly prohibited while taking the Inbec tablet, as this may interfere with the treatment. Hence, it is important to always discuss with the doctor before using the medicine.
- ● Driving: Inbec Tablet can cause dizziness, fatigue or headache. Patients should avoid driving or heavy machinery if they feel any symptoms.
- ● Pregnancy: Inbec Tablet should be taken during pregnancy if it is correctly prescribed under doctor's guidance.
- ● Breastfeeding: Women who breastfeed their child should consult a healthcare expert, as the Inbec Tablet may harm the baby, so it is better to consult with the doctor.
- ● Kidney: Patients with kidney disease should use the Inbec tablet with caution and only under strict medical supervision.
- ● Liver: Patients with liver problems should inform their doctor while taking the Inbec Tablet (Abacavir/Dolutegravir/Lamivudine), as dose adjustment should be needed.
FAQs About Inbec Tablet
1. What Abacavir/Dolutegravir/Lamivudine Tablet (Inbec) work for?
Inbec Tablet is used to reduce the viral load of HIV infection from the body by blocking the enzyme that is responsible for the multiplication of the virus.
2. How long Inbec Tablet (Abacavir/Dolutegravir/Lamivudine)should be taken?
The dose and duration of Inbec Tablet depend on the condition of the patient. The tablet must always be consumed as instructed by the doctor, and one should never discontinue its use or adjust the dosage without consulting a physician.
3. Can I take Abacavir/Dolutegravir/Lamivudine Tablet (Inbec) with other medication as well?
Yes, you can take Inbec Tablet with a combination of medications, but it is better to get advice from a healthcare professional before using it.
4. Does Inbec Tablet show any side effects?
People experience various side effects after using the Inbec Tablet. If you feel any of the symptoms, please visit the doctor promptly.
5. Do pregnant women take Inbec Tablet?
There is insufficient information to determine the safety of Inbec tablets in pregnancy. As a result, it is advisable for pregnant women to seek guidance from their doctor before using the medicine and also take it at the recommended dosage.
References
● Greig, S. L., & Deeks, E. D. (2015). Abacavir/dolutegravir/lamivudine single-tablet regimen: a review of its use in HIV-1 infection. Drugs, 75(5), 503-514.
● Christensen, B. L., & Tan, D. H. (2022). An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV. Expert Opinion on Pharmacotherapy, 23(4), 439-446.
● Walmsley, S. L., Antela, A., Clumeck, N., Duiculescu, D., Eberhard, A., Gutiérrez, F., ... & Nichols, G. (2013). Dolutegravir plus abacavir–lamivudine for the treatment of HIV-1 infection. New England Journal of Medicine, 369(19), 1807-1818.
● Cruciani, M., & Malena, M. (2015). Combination dolutegravir–abacavir–lamivudine in the management of HIV/AIDS: clinical utility and patient considerations. Patient preference and adherence, 299-310.
● Mendoza, I., Lázaro, A., & Torralba, M. (2022). Effectiveness, durability, and safety of dolutegravir and lamivudine versus dolutegravir, lamivudine, and abacavir in a real-life cohort of HIV-infected adults. Annals of Pharmacotherapy, 56(4), 412-421.
Marketer Details
Emcure
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.


